US Stocks
/
Celcuity Inc. Share Price
Celcuity Inc. Share Price

Celcuity Inc. Share Price

NASDAQ: CELC | Mid Cap
$67.76
-$0.03 (-0.04%) Last updated on 09 Oct, 2026 | 22:15 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Celcuity Inc. Stock Performance

Open
$68.18
Prev. Close
$67.79
Circuit Range
N/A
Day Range
$66.98 - $68.45
Year Range
$45.32 - $151.01
Volume
32,986
Average Traded
$67.74

Celcuity Inc. Share Price Today

As of 9 October 2026, Celcuity Inc.'s share price is $67.76. The stock opened at $68.18, compared to its previous close of $67.79. During today's trading session, Celcuity Inc.'s share price traded between $66.98 and $68.45, with an average price of $67.72. Over the past 52 weeks, the stock has recorded a high of $151.01 and a low of $45.32. In terms of performance, Celcuity Inc.'s share price has declined by 44.17% over the last six months and is down 12.17% on a year-on-year basis.

Celcuity Inc. Share Price Chart

$66.98$68.45
L
Show Current Price
H

Celcuity Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.17B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.63
Revenue (TTM)
$0.00
Return On Equity (TTM)
1772.02%
Profit Margin
N/A
Debt to Equity
-58.93
Quarterly Earnings Growth YoY
-80.05%

Celcuity Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$43.80-$50.97-$52.84-$78.86
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-16.37%-3.67%-49.24%

Celcuity Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$40.37-$63.78-$111.78-$177.04
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-57.99%-75.26%-58.38%

About Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.

Celcuity Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$78.93
$67.83
-14.80%
Sep 2026
$90.94
$79.62
-14.67%
Aug 2026
$84.91
$93.31
+7.89%
Jul 2026
$105.78
$86.48
-17.41%
Jun 2026
$130.32
$104.71
-21.04%
May 2026
$120.75
$132.61
+9.27%
Apr 2026
$117.56
$121.36
+6.40%
Mar 2026
$110.89
$114.06
+2.08%
Feb 2026
$111.14
$111.74
+2.13%
Jan 2026
$99.71
$109.41
+9.80%
Dec 2025
$100.25
$99.64
-1.51%
Nov 2025
$77.72
$101.17
+31.13%

CELC Share Price FAQs

What is Celcuity Inc. share price today?

chevron-up
Celcuity Inc. share price today is $67.76 as on October 9, 2026 at 10:15 pm IST.

What is the 52 week high and 52 week low of Celcuity Inc. stock?

chevron-up
The 52 week high of Celcuity Inc. stock is $151.01, while the 52 week low is $45.32 as of 9 Oct '26.

What is CELC's market capitalisation today?

chevron-up
CELC market capitalisation is $3.17B as of October 9, 2026, at 10:15 pm IST.

What is CELC's net income for the last quarter?

chevron-up
CELC's net income for the last quarter is -78.86B USD.

What is the 5 year returns of CELC?

chevron-up
The 5 year returns of CELC is 273.54% as on 9 Oct '26.

What is the high & low stock price of CELC today?

chevron-up
CELC stock price hit a high of $68.45 and low of $66.98 as of 9 Oct '26.

Can I buy CELC shares in India?

chevron-up
Yes. You can buy CELC in India by opening an international trading account.